PFM
Privium Fund Management Portfolio holdings
AUM
$464M
1-Year Return
124.83%
This Quarter Return
+18.86%
1 Year Return
+124.83%
3 Year Return
+508.69%
5 Year Return
–
10 Year Return
–
AUM
$402M
AUM Growth
+$9.94M
(+2.5%)
Cap. Flow
-$17M
Cap. Flow
% of AUM
-4.23%
Top 10 Holdings %
Top 10 Hldgs %
65.74%
Holding
141
New
12
Increased
36
Reduced
12
Closed
59
Top Buys
| 1 |
AST SpaceMobile
ASTS
|
$21.5M |
| 2 |
Occidental Petroleum
OXY
|
$4.18M |
| 3 |
NVIDIA
NVDA
|
$1.94M |
| 4 |
Merck
MRK
|
$1.85M |
| 5 |
Moderna
MRNA
|
$1.15M |
Top Sells
| 1 |
Occidental Petroleum Corporation Warrants to Purchase Common Stock
OXY.WS
|
$20.1M |
| 2 |
CrowdStrike
CRWD
|
$5.88M |
| 3 |
Alnylam Pharmaceuticals
ALNY
|
$4.8M |
| 4 |
Snowflake
SNOW
|
$3.89M |
| 5 |
ASTSW
AST SpaceMobile, Inc. Warrant
ASTSW
|
$3.71M |
Sector Composition
| 1 | Technology | 28.91% |
| 2 | Consumer Discretionary | 27.03% |
| 3 | Healthcare | 24.48% |
| 4 | Communication Services | 15.36% |
| 5 | Energy | 1.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Occidental Petroleum
OXY
$45.8B
| $4.18M | 1.04% |
+81,192
| New | +$4.18M |
|
27
uniQure
QURE
$924M
| $3.67M | 0.91% |
744,916
+104,500
| +16% | +$515K |
|
|
28
Moderna
MRNA
$9.31B
| $2.71M | 0.67% |
40,482
+17,221
| +74% | +$1.15M |
|
29
Acadia Pharmaceuticals
ACAD
$4.31B
| $2.28M | 0.57% |
148,400
| – | – |
|
30
Ambev
ABEV
$33.8B
| $1.52M | 0.38% |
622,314
-13,600
| -2% | -$33.2K |
|
31
CRISPR Therapeutics
CRSP
$4.72B
| $1.43M | 0.35% |
30,347
+3,000
| +11% | +$141K |
|
32
Avidity Biosciences
RNA
$6.11B
| $1.18M | 0.29% |
25,600
+3,358
| +15% | +$154K |
|
33
Krystal Biotech
KRYS
$4.32B
| $1.16M | 0.29% |
6,350
-70
| -1% | -$12.7K |
|
34
4D Molecular Therapeutics
FDMT
$288M
| $1.06M | 0.26% |
98,500
+58,500
| +146% | +$632K |
|
35
ALX Oncology
ALXO
$56.2M
| $926K | 0.23% |
509,059
+112,093
| +28% | +$204K |
|
36
MeiraGTx Holdings
MGTX
$599M
| $892K | 0.22% |
213,960
+10,000
| +5% | +$41.7K |
|
37
Citigroup
C
$177B
| $802K | 0.2% |
12,804
+326
| +3% | +$20.4K |
|
38
Franco-Nevada
FNV
$36.5B
| $753K | 0.19% |
6,061
+3,691
| +156% | +$459K |
|
|
AUTL
39
Autolus Therapeutics
AUTL
$381M
| $674K | 0.17% |
185,639
+25,000
| +16% | +$90.8K |
|
40
Pfizer
PFE
$139B
| $636K | 0.16% |
21,978
-14,142
| -39% | -$409K |
|
41
NOV
NOV
$4.9B
| $606K | 0.15% |
37,925
-1,794
| -5% | -$28.7K |
|
42
American International
AIG
$45.1B
| $588K | 0.15% |
8,024
-465
| -5% | -$34.1K |
|
43
Peabody Energy
BTU
$2.15B
| $561K | 0.14% |
21,140
+5,900
| +39% | +$157K |
|
44
Pan American Silver
PAAS
$12.1B
| $553K | 0.14% |
26,484
+3,500
| +15% | +$73K |
|
|
AZEK
45
DELISTED
The AZEK Co
AZEK
| $541K | 0.13% |
11,550
+2,950
| +34% | +$138K |
|
46
Dyne Therapeutics
DYN
$1.86B
| $539K | 0.13% |
15,016
+1,000
| +7% | +$35.9K |
|
|
SA
47
Seabridge Gold
SA
$1.77B
| $539K | 0.13% |
32,087
+4,253
| +15% | +$71.4K |
|
48
Recursion Pharmaceuticals
RXRX
$1.96B
| $514K | 0.13% |
78,000
+26,000
| +50% | +$171K |
|
49
Interface
TILE
$1.61B
| $508K | 0.13% |
+26,800
| New | +$508K |
|
50
Valaris
VAL
$3.63B
| $424K | 0.11% |
7,611
-523
| -6% | -$29.2K |
|